Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEsure Group Regulatory News (ESUR)

  • There is currently no data for ESUR

Director/PDMR Shareholding

22 Mar 2017 13:53

RNS Number : 2259A
esure Group plc
22 March 2017
 

esure Group plc

 

Notification of Transactions of Directors, Person Discharging Managerial Responsibilities ("PDMRs")

 

The information contained in this notification is disclosed in accordance with the requirements of the EU Market Abuse Regulation.

 

Strategic Leadership Plan

 

esure Group plc (the "Company") announces that on 20 March 2017 Stuart Vann and Darren Ogden, Directors of the Company, and persons' discharging managerial responsibilities were each granted an option over ordinary shares of 1/12p each in the Company under the esure Group plc 2016 Strategic Leadership Plan.

 

The vesting of the Awards is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. The awards will normally vest on the third anniversary of grant and the determination of the performance conditions. No consideration was paid for the grant of the awards. The Awards will become exercisable on 20 March 2020. Details are provided below.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

1. Stuart Vann

2. Darren Ogden

2.

Reason for the notification

a)

Position / status

1. Chief Executive Officer

2. Chief Finance Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the Issuer

a)

Name

esure Group plc

b)

LEI

213800KOI3F5LM54PT80

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

esure Group plc ordinary shares of 1/12 pence

ISIN: GB00B8KJH563

b)

Nature of the transaction

Grant of options under the esure Group plc 2016 Strategic Leadership Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£2.414 (exercise price per share)

543,185

£2.414 (exercise price per share)

309,258

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

20 March 2017

f)

Place of the transaction

Grant of the options occurred outside a trading venue

 

Enquiries:

Alice Rivers, Company Secretary

Tel: 01737 235504

 

22 March 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUUVORBUAOUAR
Date   Source Headline
14th Aug 20183:20 pmRNSForm 8.3 - esure Group plc
14th Aug 20183:20 pmRNSForm 8.3 - eSure Group plc
14th Aug 20183:13 pmRNSForm 8.3 - esure Group plc
14th Aug 20183:01 pmRNSForm 8.3 - Esure Group Inc
14th Aug 20181:59 pmRNSForm 8.3 - [esure Group plc]
14th Aug 20181:48 pmRNSForm 8.3 - esure Group plc
14th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - esure Group Plc
14th Aug 201811:33 amRNSForm 8.5 (EPT/RI) Esure Group Plc
14th Aug 201811:03 amPRNForm 8.3 - ESURE GROUP PLC
14th Aug 201810:32 amRNSForm 8.5 (EPT/RI)
14th Aug 20189:19 amPRNForm 8.3 - esure Group PLC
14th Aug 20187:00 amRNSOffer by Blue (BC) Bidco Limited
14th Aug 20187:00 amRNS2018 Interim results and proposed acquisition
13th Aug 201811:01 amRNSPossible Offer
4th Jul 201811:03 amRNSHolding(s) in Company
3rd Jul 20188:20 amRNSTotal Voting Rights
28th Jun 201812:25 pmRNSDirectorate Change
8th Jun 20183:08 pmRNSHolding(s) in Company
1st Jun 20189:12 amRNSTotal Voting Rights
18th May 20184:36 pmRNSAGM Results
4th May 20189:16 amRNS2017 Solvency & Financial Condition Report
3rd May 20187:00 amRNS2018 Q1 Trading Update
1st May 20183:42 pmRNSTotal Voting Rights
16th Apr 20184:28 pmRNSHolding(s) in Company
13th Apr 20182:55 pmRNSNotice of Annual General Meeting and Annual Report
3rd Apr 20183:15 pmRNSBlock listing Interim Review
3rd Apr 20183:09 pmRNSTotal Voting Rights
28th Mar 20188:00 amRNSDirector/PDMR Shareholding
21st Mar 20183:58 pmRNSDirector/PDMR Shareholding
21st Mar 20183:53 pmRNSDirector/PDMR Shareholding
21st Mar 20183:52 pmRNSDirector/PDMR Shareholding
8th Mar 20183:00 pmRNSAdditional Listing
7th Mar 20187:00 amRNS2017 Preliminary results
1st Mar 20189:59 amRNSTotal Voting Rights
28th Feb 20189:06 amRNSDirectorate Change
20th Feb 20188:23 amRNSNotice of Results
1st Feb 201810:04 amRNSTotal Voting Rights
19th Jan 20187:00 amRNSDirectorate Change & Trading Update
2nd Jan 20183:27 pmRNSTotal Voting Rights
1st Dec 20173:59 pmRNSTotal Voting Rights
8th Nov 20177:00 amRNS2017 Q3 Trading Update
2nd Nov 201712:43 pmRNSNotice of 2017 Q3 Trading Update
1st Nov 20179:24 amRNSTotal Voting Rights
10th Oct 20172:41 pmRNSHolding(s) in Company
10th Oct 201711:21 amRNSHolding(s) in Company
3rd Oct 20172:59 pmRNSAdditional Listing
2nd Oct 20179:53 amRNSBlock listing Interim Review
2nd Oct 20179:42 amRNSTotal Voting Rights
23rd Aug 20179:56 amRNSDirector Declaration
3rd Aug 20177:00 amRNS2017 Interim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.